In melanoma, small cell lung cancer, and kidney cancer, specific PD-1 and PD-L1 immune checkpoint inhibitors (anti-PD-L1/PD-1) have shown therapeutic effects beyond traditional radiotherapy and chemotherapy8. The gene discussed is CD274; the disease is melanoma.